Analytical derivation of time required for dissolution of monodisperse drug particles

Journal of Pharmaceutical Sciences

Volumn 93, Issue 8, 2004, Pages 1941-1944

  Sertsou, Gabriel ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG SYNTHESIS; MODEL; NOTE; SOLID; SURFACE PROPERTY;

EID: 3843104851     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20119     Document Type: Note

References (15)

1. Nernst W. 1904. Theorie der reaktiongeshcwindigkeit in heterogenen systemen. Z Phys Chem 47: 52-55.
2. Brunner E. 1904. Reaktiongeshcwindigkeit in heterogenen systemen. Z Phys Chem 47:56.
3. Higuchi WI, Hiestand EN. 1963. Dissolution rates of finely divided powders I. Effect of a distribution of particle sizes in a diffusion-controlled process. J Pharm Sci 52:67-71.
4. Healy AM, McCarthy LG, Gallagher KM, Corrigan OI. 2002. Sensitivity of dissolution rate to location in the paddle dissolution apparatus. J Pharm Pharmacol 54:441-444.
5. Mauger J, Howard S. 1976. Model systems for dissolution of finely divided (multisized) drug powders. J Pharm Sci 65:1042-1045.
6. Hintz RJ, Johnson KC. 1989. The effect of particle size distribution and dissolution rate on oral absorption. Int J Pharm 51:9-17.
7. Lu ATK, Frisella ME, Johnson KC. 1993. Dissolution modeling: Factors affecting the dissolution rates of poly disperse powders. Pharm Res 10:1308-1314.
8. Hixson AW, Crowell JH. 1931. Dependence of reaction velocity upon surface and agitation I. Theoretical consideration. Ind Eng Chem 23:923-931.
9. Martin A. 1993. Physical pharmacy, 4th ed. Philadelphia: Lea & Febiger. p 331.
10. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25.
11. Sertsou G, Butler J, Hempenstall J, Rades T. 2002. Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug. J Pharm Pharmacol 54:1041-1047.
12. Dressman JB, Fleisher D. 1986. Mixing tank model for predicting dissolution rate control of oral absorption. J Pharm Sci 75:109-116.
13. Oh D, Curl RL, Amidon GL. 1993. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: A mathematical model. Pharm Res 10:264-270.
14. Amidon GL, Lennernas H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-420.
15. Johnson KC. 2003. Dissolution and absorption modeling: Model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestine permeability, and controlled release on drug absorption. Drug Dev Ind Pharm 29:833-842.